Oscar Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.7B | $9.2B | $5.9B | $4.0B | $1.8B |
| Selling, general & administrative | $2.0B | $1.8B | $1.4B | $1.3B | — |
| Operating income | -$396.4M | $57.3M | -$235.6M | -$589.9M | -$544.5M |
| Interest expense | $17.6M | $23.7M | $24.6M | $22.6M | $4.7M |
| Pretax income | -$437.3M | $33.4M | -$267.3M | -$610.1M | -$570.6M |
| Income tax expense | $5.6M | $7.3M | $3.3M | -$523,000 | $846,000 |
| Net income | -$443.2M | $25.4M | -$270.7M | -$606.3M | -$572.6M |
| Balance Sheet | |||||
| Cash and equivalents | $2.8B | $1.5B | $1.9B | $1.6B | $1.1B |
| Current assets | $4.6B | $2.8B | $3.1B | $4.1B | $2.3B |
| Total assets | $6.3B | $4.8B | $3.6B | $4.5B | $3.3B |
| Current liabilities | $4.9B | $3.5B | $2.4B | $3.3B | $1.9B |
| Total liabilities | $5.3B | $3.8B | $2.8B | $3.6B | $1.9B |
| Stockholders' equity | $977.6M | $1.0B | $804.0M | $890.4M | $1.4B |
| Cash Flow Statement | |||||
| Cash from operations | $1.1B | $978.2M | -$272.2M | $380.3M | -$181.7M |
| Depreciation and amortization | $28.9M | $32.1M | $30.7M | $15.3M | $14.6M |
| Stock-based compensation | $87.7M | $109.8M | $159.7M | $112.3M | $86.3M |
| Capital expenditure | $36.4M | $27.9M | $25.6M | $29.0M | $25.9M |
| Free cash flow | $1.1B | $950.3M | -$297.7M | $351.3M | -$207.6M |
| Share repurchases | — | — | — | — | $0 |
Shares outstanding 301.5M · Free float 73.6%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.